The Europe Bowel Management Systems Market would witness market growth of 3.1% CAGR during the forecast period (2019-2025). Management of the neurogenic bladder and intestines includes treatment options that can help control when a patient urinates or has a bowel movement. Sometimes, a spinal cord injury prevents communication in the spinal cord between the brain and the nerves that regulate the functioning of the bladder and the bowel.
This can cause inflammation of the bladder and bowels known as neurogenic bladder or neurogenic bowel. People with multiple sclerosis or may have related problems with spina bifida. Neurogenic bladder signs and symptoms can include loss of bladder control, bladder emptying failure, urinary frequency, and urinary tract infections. Neurogenic bowel symptoms include bowel loss control, constipation, bowel frequency and lack of bowel movements.
Fecal incontinence (FI), also known as bowel incontinence, poses a significant problem for the effective and comprehensive treatment of acute and critically ill patients in nursing. The symptoms of fecal incontinence can vary from mild skin irritation to more severe conditions including extreme perineal dermatitis, altered water absorption in the intestinal tract, the transmission of infections, and sepsis when expressed as diarrhea. Fecal incontinence can be a major risk factor for Clostridium difficile and Norovirus transmission, which is commonly transmitted via the fecal-oral route. It reflects contamination of HCWs and patients ' heads, as well as contamination in the patient care community. Family and visitors to the patient are also at risk of cross-contamination.
Effective fecal management systems (FMSs) provide for stool containment and diversion, which is either consistent with liquid or semi-liquid. The FMS helps to keep the skin clean, dry, and free from pollutants and moisture that lead to skin breakdown while also avoiding contamination of the healthcare workers' (HCWs) hands and the environment of patient care.
Based on Product, the market is segmented into Irrigation Systems, Colostomy Bags, Nerve Modulation Devices and Other Products. Based on End Use, the market is segmented into Home Care and Hospitals and Ambulatory Surgery Centers. Based on Patient Category, the market is segmented into Pediatric and Adult. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: Bowel Management Systems Market in Europe is expected to register a CAGR of 3.1% during the forecast period (2019-2025)
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Coloplast Group, 3M Company, Medtronic PLC, B. Braun Melsungen AG, Becton, Dickinson and Company, Axonics Modulation Technologies, Inc., ConvaTec Group PLC, Wellspect Healthcare AB (Dentsply Sirona), Consure Medical, and Prosys International Ltd.
Market Segmentation:
By Product
By End Use
By Patient Category
By Country
Companies Profiled
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
